Does it matter? Discounting and its role in the cost-effectiveness of preventative interventions. The case of HPV vaccination

作者: H. Starkie Camejo , X. Li , G. Van Kriekinge

DOI: 10.1016/J.PUHE.2015.02.028

关键词: DiscountingFamily medicineCervical cancerCervical intraepithelial neoplasiaGynecologyGenital wartsQuality-adjusted life yearPsychological interventionMedicineCost effectivenessNice

摘要: Abbreviations: bHPV, AS04-adjuvanted HP warts; HPV, human papillomavirus; NICE, N HPV-6/11/16/18 vaccine. * Previous congress activities: These data h November 2013. Corresponding author. GSK Vaccines, Stock þ44 208 9902931. E-mail address: helen.j.starkie-camejo@g http://dx.doi.org/10.1016/j.puhe.2015.02.028 0033-3506/© 2015 GlaxoSmithKline Biologica cense (http://creativecommons.org/licenses/ the profiles of bHPV and qHPV differ markedly, which has triggered comparative assessment on costs benefits

参考文章(8)
Jacques Ferlay, Hai-Rim Shin, Freddie Bray, David Forman, Colin Mathers, Donald Maxwell Parkin, Estimates of worldwide burden of cancer in 2008: GLOBOCAN 2008. International Journal of Cancer. ,vol. 127, pp. 2893- 2917 ,(2010) , 10.1002/IJC.25516
Gwenda Hughes, Rebecca Howell-Jones, Kate Soldan, Sally Wetten, David Mesher, Tim Williams, O. Noel Gill, Declining Genital Warts in Young Women in England Associated With HPV 16/18 Vaccination: An Ecological Study The Journal of Infectious Diseases. ,vol. 208, pp. 1397- 1403 ,(2013) , 10.1093/INFDIS/JIT361
Fawziah Marra, Eric Young, Simon R. M. Dobson, Shelly McNeil, Marc Dionne, Meena Dawar, Gina Ogilvie, Mel Krajden, Chantal Sauvageau, David W. Scheifele, Tobias R. Kollmann, Scott A. Halperin, Joanne M. Langley, Julie A. Bettinger, Joel Singer, Deborah Money, Dianne Miller, Monika Naus, Immunogenicity of 2 doses of HPV vaccine in younger adolescents vs 3 doses in young women: a randomized clinical trial. JAMA. ,vol. 309, pp. 1793- 1802 ,(2013) , 10.1001/JAMA.2013.1625
Nadia Demarteau, Chao-Hsiun Tang, Hui-Chi Chen, Chien-Jen Chen, Georges Van Kriekinge, Cost-Effectiveness Analysis of the Bivalent Compared with the Quadrivalent Human Papillomavirus Vaccines in Taiwan Value in Health. ,vol. 15, pp. 622- 631 ,(2012) , 10.1016/J.JVAL.2012.02.012
Mehreteab Aregay, Ziv Shkedy, Geert Molenberghs, Marie-Pierre David, Fabián Tibaldi, Model-based estimates of long-term persistence of induced HPV antibodies: a flexible subject-specific approach. Journal of Biopharmaceutical Statistics. ,vol. 23, pp. 1228- 1248 ,(2013) , 10.1080/10543406.2013.834917
D Descamps, F Struyf, M Lehtinen, G Dubin, J Paavonen, P Naud, J Salmerón, CM Wheeler, S-N Chow, D Apter, H Kitchener, X Castellsague, JC Teixeira, SR Skinner, J Hedrick, U Jaisamrarn, G Limson, S Garland, A Szarewski, B Romanowski, FY Aoki, TF Schwarz, WAJ Poppe, FX Bosch, D Jenkins, K Hardt, T Zahaf, Efficacy of human papillomavirus (HPV)-16/18 AS04-adjuvanted vaccine against cervical infection and precancer caused by oncogenic HPV types (PATRICIA): final analysis of a double-blind, randomised study in young women. The Lancet. ,vol. 374, pp. 301- 314 ,(2009) , 10.1016/S0140-6736(09)61248-4
S. Desai, S. Wetten, S. C. Woodhall, L. Peters, G. Hughes, K. Soldan, Genital warts and cost of care in England Sexually Transmitted Infections. ,vol. 87, pp. 464- 468 ,(2011) , 10.1136/STI.2010.048421